This history is largely about the players on the stage of the Yale Pathology Department acting out their roles as observed by the author in over a half century as a member of the department and as associate dean of the medical school.
INTRODUCTION
The modem department of pathology at the Yale University School of Medicine was established by a thirty-four-year-old associate professor of pathology from The Johns Hopkins University named Milton C. Winternitz ( Figures 1 and 5 ) [1] who had trained under the legendary pathologist William H. Welch [2] . Welch had worked in the laboratories of Koch and Cohnheim in Europe and had brought back the excitement of scientific discovery to The Johns Hopkins University, where he became dean of its School of Medicine. Because Winternitz was Jewish, Welch advised him that he could not be promoted to full professor at Hopkins, since, at the time, one had to be white, male, Protestant, and preferably rich, to occupy leadership positions in medicine. On the other hand, Welch found the contributions from Yale [3] , that Yale needed a full-time faculty, more basic science, more laboratories and an endowment. Less than half the medical schools in the United States met the standards of Flexner's report and managed to survive [4] . Winternitz set about getting a better curriculum, better students, more money, laboratories and fewer didactic lectures. In 1922, the chairman of the curriculum committee said that the Yale student had become the "defenseless recipient of an overwhelming mass of facts which he may or may not be able to correlate" [5] . investigation and the value of research [5] . In 1932, Winternitz accepted passage of the National Board examinations as a requirement to enter the third year. Over the years, "The Yale System" has repeatedly been reaffirmed by the Yale faculty (albeit with significant changes).
Pathology research
The great flu pandemic of 1918-1919 filled the New Haven Hospital with hundreds of patients, of whom many died and were autopsied. The pathology findings were discussed by Winternitz in a book he published in 1921 [6] . It urine of a putatively pregnant woman (as a source of HCG); one had only to look the animal in the eye to see whether ovulation was induced.
In addition to embryonic tissue, Greene found that malignant tissue would grow in the eye. Since carcinoma in situ and occult carcinoma did not survive transfer, he believed truly malignant cells were not present in these conditions. Also, since lymphomas, myelosarcomas and leukemia did not survive such transfers, he concluded that they, too, were not neoplastic diseases.
He implied that pathologists, on the whole, were lazy and perhaps even dishonest; he even compared them to WPA workers as recipients of official "make-work" charity. In 1944, such statements caused a considerable uproar [7] . G.H. Twombley replied:
(The pathologist) is the primary person one relies on. He cannot be dishonest because his dishonesty is so quickly discovered. If we had to wait two or three months for the results of transplantation to tell whether or not a woman has cancer of the breast, the results from therapy would be very poor. A good pathologist ought to be able to diagnose cancer in at least ninety out of one-hundred cases. Morphological research may be very dead, but the work that the morphological pathologist does is anything but dead. [7] Jacob Furth opposed Greene's views and noted that leukemia cells could be passed on to new hosts almost indefinitely, which could be done with immature, normal cells. "This is certainly autonomy" [7] .
Greene succeeded Wintemitz as chairman of pathology, despite the fact that he did not believe pathologists contributed anything, and would not bring them into his department. He dressed in operating room garb, and delighted in taking unconventional positions. He lost no opportunity in putting down Republicans, and could be even more insulting. He referred to visiting attorney Melvin Belli as "Bell-E," and when Belli protested, Greene said when "spaghetti" was pronounced "spaghett-eye," he would call him Belli [8] . When I once asked him why he came to Yale, Greene said he liked to open the window and smell skunk. Of course, stories about him abounded, and his reputation always attracted an overflow crowd when he spoke in Fitkin Amphitheater.
For example, Greene took a position contrary to the mounting evidence that smoking was contributing to lung cancer. He had, he said, taken some of the "crud" from his pipe and put it in the subcutaneous tissue of a rabbit, along with some embryonic tissue. Since no cancer resulted, it indicated that the tobacco residue was not carcinogenic. The attribution of the rise of lung cancer to the rise of cigarette smoking was, he said, a parallel phenomenon. Since there was a simultaneous rise in the wearing of nylon stockings, one might say this was the cause of lung cancer [9] .
His behavior at times could be outrageous. introduction of a series of pneumonias, which he called "usual interstitial pneumonia" (UIP), "desquamative interstitial pneumonia" (DIP), "lymphoid interstitial pneumonia" (LIP) and "proteinosis" [13] . He There were twenty-seven separate clinical laboratories at Yale. Blood iodine measurements were done in pharmacology, renal function tests in Frank Epstein's laboratory, liver function tests in Klatskin's laboratory, both in the department of internal medicine, and there was a separate laboratory for pediatric bacteriology. David Seligson, from Philadelphia, was invited to consolidate these disparate labs into a single clinical pathology laboratory. He applied for certification in clinical chemistry and was made a Diplomate of the National Boards on a "grandfather" clause. We arranged to have the VA residents rotate through his chemistry section for six months to learn the more labor intensive belt-line analytic system he used in contrast to the autoanalyzer system I had installed at the VA in 1958, and which proved to be a very successful technological advance.
Integration of the VA Hospital with the Yale School of Medicine proceeded rapidly, except for pathology services. Greene refused to allow Yale residents to rotate through the VA for training; instead, he sent them there to do autopsies at a specified charge of $75 per autopsy. We protested that it would be unfair to the clinical services for pathology alone to remain unintegrated. At the next Dean's Committee meeting, Paul Beeson, chair of the department of internal medicine, said the situation was intolerable, that integration was a contract between Yale and the VA as institutions, and that individual services had no choice. He regarded the VA as a "pearl beyond price," which was allowing a great increase in staff and in clinical and research opportunities. After the Dean's Committee meeting, integration of pathology occurred.
In the meantime, because of the decline in the number of hospitalized TB patients, the TB building simply became known as Building No Figure 6 ) was subsequently recruited, coming from New York University where he was chairman of internal medicine and dean of the School of [21] then returned to do surgical pathology. Autopsy pathology had been declining throughout the western world for many years for many reasons including the proliferation of technological techniques, the cost, the long delays, the fear of lawsuits, the lack of payment (not compensated by third-party payers) and lack of research grants. Most pathologists, it seems, would prefer to do something else. Walker Smith, a disciple of Liebow, was in charge of autopsy pathology and also director of the residency program in pathology.
Under the leadership of Thomas and Marchesi, the pathology department became strongly committed to research in immunology, which had previously been scorned. Its first prominent research work was represented by Richard Gershon. Having lost neuropathology to neurosurgery, and most of dermatopathology to dermatology, pathologic anatomy needed strong leadership, and Juan Rosai was brought from Minnesota to be the director of anatomic pathology as well as of the residency program.
RECENT DEVELOPMENTS Because of increased specialized knowledge, surgical pathology was compartmentalized by organ systems, with a particularly heavy load in areas such as gastroenterology and gynecologic pathology. A section of fine needle aspirations has been introduced recently as well.
With help from the Howard Hughes Medical Institute and Herbert Boyer, the construction of a new building devoted to basic biomedical research, the Boyer Center for Molecular Medicine, was completed and Marchesi was named its director. These laboratories are directly connected by a bridge to the pathology department. Marchesi was mentor to Jon Morrow, who succeeded him as chair of pathology, which has been modernized and computerized. New research laboratories have been built as well as a new morgue to house the autopsy service. A Decedent Affairs Office has been organized, to increase the efficiency of handling autopsies, which remain an important part of teaching. Rosai has gone to Sloan-Kettering Memorial Hospital to be its director of pathology, and he has been replaced by Jose Costa, who is vice-chair of pathology, deputy director of the Yale Comprehensive Cancer Center and director of critical technologies.
The department of pathology at Yale is poised to enter the twenty-first century with one leg strongly planted in pathologic anatomy and a second leg in molecular biology, joined together in the body of pathology.
